Kestra Advisory Services’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,071
Closed -$72.1K – 3545
2025
Q4
$72.1K Buy
+2,071
New +$76.4K ﹤0.01% 3685
2022
Q2
– Sell
-5,885
Closed -$230K – 2169
2022
Q1
$230K Buy
+5,885
New +$228K ﹤0.01% 1758

Other funds holding FFTY

Kestra Advisory Services's FFTY Position: Q1 2026 in Review

Kestra Advisory Services sold out of CapForce IBD 50 ETF (FFTY) in Q1 2026, closing a stake of 2,071 shares — an estimated $72.1K sold.

Kestra Advisory Services first reported a position in FFTY in Q1 2022 and held it in 2 quarters. The position peaked at $230K in Q1 2022. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • Kestra Advisory Services reported no remaining CapForce IBD 50 ETF position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 2,071 CapForce IBD 50 ETF shares in Q1 2026, an estimated $72.1K.
  • Kestra Advisory Services first reported a position in CapForce IBD 50 ETF in Q1 2022 and held it in 2 quarters.
  • Kestra Advisory Services's CapForce IBD 50 ETF position peaked at $230K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.